So this is the frustration. Not that you don't have a product, not that you don't have your free product, but where is the company in responding to this outcry that I have received and every Member of Congress?
Lawrence expresses frustration over the company's response to public outcry regarding EpiPen pricing.
Share & report
More from Brenda Lawrence
We just passed the most transformational transportation investment in infrastructure that we've had since the new deal.
One of the things when we’re approaching Martin Luther King, and one of the deadly sins in our country is that loud voice of silence, where people, good people sit on the sideline and allow those who are promoting hate, promoting untruths…
I am asking if you will commit to reviewing the letter from me and my colleagues and the critical information in forthcoming CFSRs?
We need to do something different in those areas where we know we have challenges.
Other voices in this conversation
